nexMPI

Menu
Magnetic Particle Imaging

WG 4: Biomedical applications

WG 4 Leader: Prof. Ludek Sefc

WG 4 Co-leader: Dr. Lilianne Guibert Beola

Working Group 4 (WG 4) focuses on developing novel preclinical and clinical applications of Magnetic Particle Imaging (MPI), with an emphasis on cancer and cardiovascular diseases.

Our work includes mapping key (pre)clinical requirements such as biodistribution, pharmacokinetics, pharmacodynamics, biological effects, and targeting strategies. By bridging the gap between preclinical research and clinical implementation, WG 4 aims to accelerate the translation of MPI technology into real-world medical applications.

Tasks:

  • Investigate state-of-the-art research groups employing MPI in (pre)clinical research and map their specific research topics
  • Develop guidelines for preclinical studies using MPI

  • Suggest MPI clinical trials, define metrics to assess the efficacy of MPI, and compare with established molecular imaging techniques, e.g. PET, SPECT